Skip to main content

Loading market ticker...

Natural Capsules

Healthcare NSE:NATCAPSUQ

155.95INR
2.41 ( 1.57%)

Last update at June 12, 2026, midnight

Day Range

152.21156.80
LowHigh

52 Week Range

160.00 296.00
LowHigh

Fundamentals

  • Previous Close 153.54
  • Market Cap 2370.30M
  • Volume2,372
  • P/E Ratio -
  • EBITDA 112.26M
  • Revenue TTM 1752.25M
  • Revenue Per Share TTM 173.50
  • Gross Profit TTM 830.63M
  • Diluted EPS TTM -5.43

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1427.60 15/05/26 15/05/26 Same Day Short Term Healthcare 0.17%
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

No income statement data available.

No balance sheet data available.

No cash flow data available.

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
NATCAPSUQ
Natural Capsules 		2.41 1.57% 155.95 2370.30 -
SUNPHARMA
Sun Pharmaceutical Industries Limited 		13.50 0.75% 1807.70 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-17.50 -0.26% 6638.00 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		-1.00 -0.02% 4571.20 1362716.66 63.48
CIPLA
Cipla Limited 		6.10 0.44% 1389.40 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.